Perennial Hldgs - Employee Stock Option/ Share Scheme::Grant of Share Options under the Perennial Employee Share Option Scheme 2014
Announcement Type: Employee Stock Option/ Share Scheme
Company: PERENNIAL REAL ESTATE HLDGSLTD
Stock Code/Name: 40S - Perennial Hldgs
Company: PERENNIAL REAL ESTATE HLDGSLTD
Stock Code/Name: 40S - Perennial Hldgs
| Employee Stock Option/ Share Scheme::Grant of Share Options under the Perennial Employee Share Option Scheme 2014 |
| Issuer & Securities |
| Issuer/ Manager | PERENNIAL REAL ESTATE HOLDINGS LIMITED |
| Securities | PERENNIAL REAL ESTATE HLDGSLTD - SG1AD8000002 - 40S |
| Stapled Security | No |
| Announcement Details |
| Announcement Title | Employee Stock Option/ Share Scheme |
| Date & Time of Broadcast | 15-May-2015 21:10:59 |
| Status | New |
| Announcement Sub Title | Grant of Share Options under the Perennial Employee Share Option Scheme 2014 |
| Announcement Reference | SG150515OTHRL2WG |
| Submitted By (Co./ Ind. Name) | Pua Seck Guan |
| Designation | Chief Executive Officer |
| Description (Please provide a detailed description of the event in the box below) | Please refer to the attachment. |
| Attachments |
|
BlackGoldNatural - Financial Statements and Related Announcement::Second Quarter and/ or Half Yearly Results
Announcement Type: Financial Statements
Company: BLACKGOLD NATURAL RESOURCESLTD
Stock Code/Name: 41H - BlackGoldNatural
Company: BLACKGOLD NATURAL RESOURCESLTD
Stock Code/Name: 41H - BlackGoldNatural
| Financial Statements and Related Announcement::Second Quarter and/ or Half Yearly Results |
| Issuer & Securities |
| Issuer/ Manager | BLACKGOLD NATURAL RESOURCES LIMITED |
| Securities | BLACKGOLD NATURAL RESOURCESLTD - SG1AH0000001 - 41H |
| Stapled Security | No |
| Announcement Details |
| Announcement Title | Financial Statements and Related Announcement |
| Date & Time of Broadcast | 15-May-2015 21:15:16 |
| Status | New |
| Announcement Sub Title | Second Quarter and/ or Half Yearly Results |
| Announcement Reference | SG150515OTHREKPZ |
| Submitted By (Co./ Ind. Name) | Philip Cecil Rickard |
| Designation | Chief Executive Officer |
| Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format) | Please see attached. |
| Additional Details |
| For Financial Period Ended | 31/03/2015 |
| Attachments |
|
IHC - Disclosure of Interest/ Changes in Interest
Announcement Type: Disclosure of Interest/ Changes in Interest
Company: INTL HEALTHWAY CORP LIMITED
Stock Code/Name: 5WA - IHC
Company: INTL HEALTHWAY CORP LIMITED
Stock Code/Name: 5WA - IHC
| Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Change in Substantial Shareholder's Interest |
| Issuer & Securities |
| Issuer/ Manager | INTERNATIONAL HEALTHWAY CORPORATION LIMITED |
| Securities | INTL HEALTHWAY CORP LIMITED - SG2F86994413 - 5WA |
| Stapled Security | No |
| Announcement Details |
| Announcement Title | Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s) |
| Date & Time of Broadcast | 15-May-2015 20:56:05 |
| Status | New |
| Announcement Sub Title | Change in Substantial Shareholder's Interest |
| Announcement Reference | SG150515OTHRT1B0 |
| Submitted By (Co./ Ind. Name) | Dr Jong Hee Sen |
| Designation | Non-Executive Chairman |
| Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format) | International Healthway Corporation Limited (the "Company") was listed on Catalist of the Singapore Exchange Securities Trading Limited (the "SGX-ST") on 8 July 2013. The initial public offering of the Company was sponsored by PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"). This announcement has been prepared by the Company and its contents have been reviewed by the Sponsor for compliance with the SGX-ST Listing Manual Section B: Rules of Catalist. The Sponsor has not verified the contents of this announcement. This announcement has not been examined or approved by the SGX-ST. The Sponsor and the SGX-ST assume no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Ms Gillian Goh, Director, Head of Continuing Sponsorship, at 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318, telephone (65) 6229 8088. |
| Additional Details |
| Person(s) giving notice | Substantial Shareholder(s)/Unitholder(s) (Form 3) |
| Date of receipt of notice by Listed Issuer | 15/05/2015 |
| Attachments |
|
Foreland FabriT - Financial Statements and Related Announcement::First Quarter Results
Announcement Type: Financial Statements
Company: FORELAND FABRICTECH HLDS LTD
Stock Code/Name: B0I - Foreland FabriT
Company: FORELAND FABRICTECH HLDS LTD
Stock Code/Name: B0I - Foreland FabriT
| Financial Statements and Related Announcement::First Quarter Results |
| Issuer & Securities |
| Issuer/ Manager | FORELAND FABRICTECH HLDS LTD |
| Securities | FORELAND FABRICTECH HLDS LTD - BMG3658Z1041 - B0I |
| Stapled Security | No |
| Announcement Details |
| Announcement Title | Financial Statements and Related Announcement |
| Date & Time of Broadcast | 15-May-2015 20:37:26 |
| Status | New |
| Announcement Sub Title | First Quarter Results |
| Announcement Reference | SG150515OTHRI1L2 |
| Submitted By (Co./ Ind. Name) | Tsoi Kin Chit |
| Designation | Executive Chairman |
| Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format) | Please refer to the attached. |
| Additional Details |
| For Financial Period Ended | 31/03/2015 |
| Attachments |
|
Tianjin ZX USD - Change - Announcement of Appointment::Change - Announcement of Appointment
Announcement Type: Announcement of Appointment
Company: TIANJIN ZHONG XIN PHARM GROUP
Stock Code/Name: T14 - Tianjin ZX USD
Company: TIANJIN ZHONG XIN PHARM GROUP
Stock Code/Name: T14 - Tianjin ZX USD
| Change - Announcement of Appointment::Change - Announcement of Appointment |
| Issuer & Securities |
| Issuer/ Manager | TIANJIN ZHONG XIN PHARM GROUP |
| Securities | TIANJIN ZHONG XIN PHARM GROUP - CNE100000924 - T14 |
| Stapled Security | No |
| Announcement Details |
| Announcement Title | Change - Announcement of Appointment |
| Date & Time of Broadcast | 15-May-2015 20:04:13 |
| Status | New |
| Announcement Sub Title | Change - Announcement of Appointment |
| Announcement Reference | SG150515OTHRYA5C |
| Submitted By (Co./ Ind. Name) | Jiao Yan |
| Designation | Secretary to the Board |
| Description (Please provide a detailed description of the event in the box below) | Director of the Company. |
| Additional Details |
| Date Of Appointment | 15/05/2015 |
| Name Of Person | Ms Wang Lei |
| Age | 44 |
| Country Of Principal Residence | China |
| The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process) | The Nominating Committee, having reviewed Ms Wang Lei s credentials, experience and capabilities, is satisfied that Ms Wang Lei is suitable for appointment as Director of the Company. |
| Whether appointment is executive, and if so, the area of responsibility | The appointment is Executive Director. |
| Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) | Executive Director |
| Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries | NIL |
| Conflict of interests (including any competing business) | NIL |
| Working experience and occupation(s) during the past 10 years | For the period from March 2001 to April 2004, she was firstly appointed as Deputy Director of Planning Division and then as the Deputy Director of Industry Department in the Company. From April 2004 to January 2013, she served as the Deputy Director, Executive Deputy Director, Secretary of the Party Committee, Director cum Deputy Secretary of the Party Committee in succession and further promoted as Director cum Secretary of the Party Committee from January 2013 to date in Tianjin Zhongxin Lerentang Pharmaceutical Factory. From 15 May 2013 to 23 June 2013, she was also a Supervisor of the Board of Supervisors of the Company. From June 2014 to present, she is working as the deputy general manger of the Company. |
| Shareholding interest in the listed issuer and its subsidiaries? | No |
| # These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8). | |
| Past (for the last 5 years) | NIL |
| Present | NIL |
| (a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? | No |
| (b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? | No |
| (c) Whether there is any unsatisfied judgment against him? | No |
| (d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? | No |
| (e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? | No |
| (f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? | No |
| (g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? | No |
| (h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? | No |
| (i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? | No |
| (i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or | No |
| (ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or | No |
| (iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or | No |
| (iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? | No |
| (k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? | No |
| Any prior experience as a director of a listed company? | No |
| If No, Please provide details of any training undertaken in the roles and responsibilities of a director of a listed company | NIL |
No comments:
Post a Comment